Teva Copaxone European Price Will Be Comparable To Competing MS Drugs
Executive Summary
Teva will launch Copaxone in Europe at a price comparable to competing multiple sclerosis therapies, North America CEO Bill Fletcher told analysts during an Aug. 15 conference call.